The c4c project aims to develop a Pan European Paediatric Clinical Trial Network. As part of the development of the c4c network we are creating a series of podcasts centred on the work of the network.
Insights from the Spanish and Norwegian National Hubs
In this episode, we had the opportunity to talk to two National Hubs, RECLIP Network from Spain and NorPedMed from Norway. Complementing each other in their differences, and enhancing each other in their similarities, they work for a common goal: safer medicines for children 🙏
Listen to this episode, we hope you enjoy it!
Why you should include PPI in your paediatric clinical trial
PPI (Patient-Parent Involvement) acts as the link between the patients and the clinicians, researchers and sponsors, incorporating their crucial voice to make better clinical trial from start to finish. Our guests, Begonya Nafria from Hospital Sant Joan de DĂ©u and Segolene Gaillard from the University Hospital of Lyon, take us through why it is important in this episode.
Listen to this episode, we hope you enjoy it!
Insights from the Greek and Belgian National Hubs
In this episode, we had the opportunity to talk to two National Hubs, BPCRN from Belgium and HELPNet from Greece. We found out the differences and similarities between the two hubs who are working together for a common goal: safer medicines for children.
To find out more about these hubs visit: https://www.bpcrn.be/Â and https://helpnet.gr/
Listen to this episode, we hope you enjoy it!
Challenges & Opportunites in Paediatric Clinical Research
Digital Innovation & Transformation
In this episode, we are discussing the Challenges and Opportunities in Pediatrics Clinical Research, as well as Digital Innovation & Transformation in this field.
Listen to this episode, we hope you enjoy it!
The Journey of the New Legal Entity
We’re back with c4c podcasts! In this episode, Mark Turner, Sabah Attar and Ricardo Fernandes take us through the transition from a publicly-funded project to a stand-alone organization.
Listen to this episode, we hope you enjoy it!
Multistakeholder Meetings
We’re back with c4c podcasts! In this episode, we’re talking to Gilles Vassal from Gustave Roussy about how multistakeholder meetings are crucial to create a more patient-centric and science-driven paediatric clinical trial landscape.
Listen to this episode, we hope you enjoy it!
Ethical principals in Paediatric Clinical Trials (for professionals)
Pirkko Lepola talks about the ethical principles in paediatric clinical trials. What are the current rules? How to set up a paediatric clinical trials by following these rules?
How can c4c support this process?
Listen to this episode, we hope you enjoy it!
Ethical principals in Paediatric Clinical Trials (for patients)
Pirkko Lepola joins us to talk about the ethical principles in paediatric clinical trials.
What are the current rules?
How to make sure to apply children’s rights?
Listen to this episode, we hope you enjoy it!
c4c’s Young Investigator Community
Today, we are joined by Eva Degraeuwe, Tessa van der Geest and Mark Turner to talk about the Young Investigators Community! This community aims to involve individuals working within the c4c network to come together and improve collaboration, education, and networking.Â
Listen back here!
What’s the KD-CAAP trial? (for patients)
Kawasaki disease is an acute febrile illness of unknown cause that primarily affects children younger than 5 years of age.
The clinical trial “KD-CAAP” studies the effectiveness of adding a new element to the standard treatment for this disease. What are the hopes for Kawasaki disease treatment and patients?
Listen to our podcast with Prof. Paul Brogan, joint chief investigator of the KD-CAAP trial to find more!
KD-CAAP trial (for professionals)
Kawasaki disease, also known as Kawasaki syndrome, is an acute febrile illness of unknown cause that primarily affects children younger than 5 years of age.
KD-CAAP proof of viability study assesses the effectiveness of adding steroids to standard treatment in children with Kawasaki Disease.
Why is it important to improve paediatric patient’s lives? How is c4c supporting this study?
Listen to our podcast with Prof. Paul Brogan, joint chief investigator of the KD-CAAP trial!
Insights from c4c’s expert groups
Franz and Saskia are both involved in the c4c methodology experts’ groups, that bring together experts in different fields intending to advise pharmaceutical companies or academic trials during a paediatric clinical trial.
How was this initiative set up? How do patients participate in these groups as well? What requests have been solved until now?
Listen to this new episode to find out!
The best kept secret of science communication
Why is Science communication essential nowadays, especially for an European Network as conect4children? How to efficiently communicate science? How to overcome the challenges around fake news?
In our new podcast episode, Claudio Fracasso and Lindsey Hunter, the c4c leads for communication, dissemination, exploitation, impact assessment, talk about the importance of science communication and its central role in c4c.
cASPerCF: Proof of viability studies to test the c4c network
c4c have released two new podcasts about cASPerCF, one of the first non-industry PoV trials to test the c4c network’s infrastructure. The cASPerCF trial aims to find the right dose of posaconazole to treat children and young people with Cystic Fibrosis and Aspergillus infection.
In the first podcast, Prof Adilia Warris provides an overview of the cASPerCF trial and in the second podcast, Jacob Bradbury providing a short overview on what Cystic Fibrosis is and how it affects children.
The how and why of COVID-19 vaccines for children
For our first podcast, we focus on Covid-19 vaccines for children and young people, with Dr Federico Martinòn-Torres. Topics that are discussed include:
- The reason behind the lack of paediatric clinical trials for COVID-19 vaccine
- The necessity of having COVID-19 vaccines for children on the herd immunity as well as on the individual side
- Social inequalities linked to school closures
- The current challenges in paediatric clinical trials for COVID-19 vaccine